Clinical Trial Update: Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas [Phase 2]

View source ↗

Summary

Phase 2 trial of pirfenidone in children and young adults with Neurofibromatosis type I and progressive plexiform neurofibromas has completed. Results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• PIRFENIDONE (pirfenidone)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurofibromatosis 1, Neurofibroma, Plexiform | Phase 2 | Status: COMPLETED | Results posted: 2012-07-12